Latest News

Climate Change and AD: New Review Shows Negative Impacts and Unknowns


 

FROM ALLERGY

A new review of the literature on climate change and atopic dermatitis (AD) found evidence of a broad and negative impact of climatic hazards on various aspects of AD, including prevalence, severity/flares, and AD-related health care utilization. But it also showed the extent to which research is lacking.

“There’s not as much out there as one might expect, given that this is the most common dermatologic disease and one of the most burdensome diseases worldwide,” said Katrina Abuabara, MD, of the department of dermatology at the University of California, San Francisco, one of the senior authors of the review.

Dr. Katrina Abuabara associate professor of dermatology and epidemiology, University of Californai, San Francisco. Dr. Abuabara

Dr. Katrina Abuabara

“There’s a genetic predisposition to AD, but it’s certainly very environmentally patterned,” she said in an interview. “Given that we know there are strong environmental influences, it’s an obvious example of how climate change affects our health ... It is one that may be underappreciated and that could give us near-term information.”

Indeed, she and her coauthors emphasized in their paper, “AD could serve as a case study for climatic impacts on health.” The review, which looked beyond the realm of air pollution, was published in Allergy, the journal of the European Academy of Allergy and Clinical Immunology.

Dr. Abuabara, UCSF dermatologist Sheng-Pei Wang, MD, MPH, and their coauthors — dermatologists and others from the United States, Europe, Brazil, and India — were convened by the International Eczema Council and teamed up with a biologist and climate science expert, Camilo Mora, PhD, of the University of Hawaii at Mānoa, Honolulu. Because research to date has focused on air pollution, with the impact of other hazards that Dr. Abuabara said were “a lot less developed and organized,” they used a framework and search strategy developed by Dr. Mora that looks at 10 climatic hazards related to greenhouse gas emissions, including heat waves, drought, precipitation, wildfires, and sea level rise.

“Given that this [framework] was already out there in the literature, we thought it would give us a structure and a nice way to organize the literature,” Dr. Abuabara said. While the literature is too heterogeneous for a systematic review and meta-analysis, the researchers used a systematic approach, she explained.

Lawrence Eichenfield, MD, professor of dermatology and pediatrics at the University of California, San Diego, and a coauthor of the paper, said in an e-mail that the review raises “our consciousness about how these [climate] changes may be impacting atopic dermatitis.”

Dr. Lawrence F. Eichenfield, professor of dermatology and pediatrics at the University of California, San Diego, and Rady Children's Hospital, San Diego Courtesy University of California, San Diego

Dr. Lawrence F. Eichenfield

Researchers have “much work to do to understand the evolving impact on AD development and course, and even more to figure out how to avoid extreme weather’s impact to minimize its effects on inflammatory skin diseases,” he said. “In the meantime, this paper is a call for the health care community to recognize a set of factors that can influence our patients’ dermatitis and lives.”

Pages

Recommended Reading

Dupilumab Effective in Patients With Atopic Dermatitis and Comorbidities Including Malignancies
MDedge Dermatology
Dupilumab Dose Reduction Achievable in Persistently Controlled Atopic Dermatitis
MDedge Dermatology
Does Dupilumab Treatment in Atopic Dermatitis Increase Infection Risk in Infants and Children?
MDedge Dermatology
Upadacitinib Shows Good Drug Survival in Moderate to Severe Atopic Dermatitis
MDedge Dermatology
Dupilumab Efficacy in Atopic Dermatitis Is Not Influenced by Pathogenic Filaggrin Variants
MDedge Dermatology
Prevalence of Risk Factors Impacting Oral Janus Kinase Inhibitor Treatment in Atopic Dermatitis
MDedge Dermatology
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
MDedge Dermatology
Company Announces Regulatory Filing for Nemolizumab for Two Indications
MDedge Dermatology
What Skin Manifestations Are Associated With Pediatric IBD?
MDedge Dermatology
Commentary: Medication Timing and Other Dupilumab Concerns, March 2024
MDedge Dermatology